Clinical Trials in Canberra, Australian Capital Territory

Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

NCT ID: NCT05263934

This clinical trial is studying a new treatment called depemokimab to see how well it works compared to another treatment called mepolizumab for adults with a condition called Eosinophilic Granulom...

A Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

NCT ID: NCT06500702

This clinical trial is studying the effectiveness and safety of three different treatments—frexalimab, SAR442970, and rilzabrutinib—in patients aged 16 to 75 years with specific kidney conditions c...

A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT ID: NCT06508658

This clinical trial is studying a new combination treatment for adult patients with diffuse large B-cell lymphoma (DLBCL), a type of aggressive cancer affecting immune cells. Researchers want to se...

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

NCT ID: NCT06875310

The KRYSTAL-4 trial is studying a new treatment approach for patients with a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has a mutation known as KRAS G12C. This tria...

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

NCT ID: NCT05325008

The BEAT-BK clinical trial is studying how different treatments can help patients who have had a kidney or simultaneous kidney and pancreas transplant and are experiencing a viral infection called ...

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

NCT ID: NCT05653349

This clinical trial is studying a medication called ianalumab to see how well it works in helping adults with a condition called primary immune thrombocytopenia (ITP) maintain a healthy platelet co...

Efficacy and Safety of HB-1 for Panic Disorder

NCT ID: NCT06483789

This clinical trial is studying a new treatment called HB-1 for individuals with Panic Disorder, which is a mental health condition that causes sudden and intense feelings of fear and anxiety. The ...

A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

NCT ID: NCT05648968

This clinical trial is studying a new treatment called ianalumab for patients with a condition known as warm autoimmune hemolytic anemia (wAIHA). This condition causes the body to destroy its own r...

Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX

NCT ID: NCT06782971

This clinical trial is focused on finding new ways to treat patients with Acute Myeloid Leukemia (AML), a type of cancer that affects the blood and bone marrow. Researchers want to see if they can ...

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

NCT ID: NCT06360094

This clinical trial is looking at a new medication called BI 1839100 to see if it can help reduce coughing in adults with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF)...

YN001-004 in Patients With Coronary Atherosclerosis in Australia

NCT ID: NCT06700720

This clinical trial, called YN001-004, is investigating a treatment called YN001 for patients with coronary atherosclerosis, a condition where the arteries that supply blood to the heart become nar...

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

NCT ID: NCT05334368

This clinical trial is studying a new treatment called depemokimab for adults with Hypereosinophilic Syndrome (HES), a condition where the body produces too many eosinophils, a type of white blood ...

Maintenance rTMS for Depression (Maitr-De)

NCT ID: NCT06938841

The Maintenance rTMS for Depression (Maitr-De) clinical trial is studying a treatment called repetitive transcranial magnetic stimulation (rTMS) for people who have major depressive disorder and ha...

Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis

NCT ID: NCT05802264

This clinical trial is investigating a new treatment called Amphotericin B Cystetic for Inhalation (ABCI) to see how safe it is and how well it works in both healthy individuals and people with cys...

SBD121, a Synbiotic Medical Food for RA Management

NCT ID: NCT06005220

This clinical trial is studying a medical food called SBD121, which combines prebiotics and probiotics, to see if it can help manage symptoms in people with early-stage rheumatoid arthritis (RA). T...

Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies

NCT ID: NCT04170283

Fibrinolysis Resistance in Infection and Trauma

NCT ID: NCT06680180

This clinical trial, titled "Fibrinolysis Resistance in Infection and Trauma," is focused on understanding blood clotting problems in critically ill patients, particularly those suffering from seve...

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

NCT ID: NCT02735707

The REMAP-CAP trial is a research study designed to find out which treatments work best for patients with community-acquired pneumonia, especially those who are very sick and need to be in the inte...

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

NCT ID: NCT05713136

The National Australian HCV Point-of-Care Testing Program is a study aimed at improving how we screen for and treat Hepatitis C, a virus that affects the liver. The researchers want to find out if ...

The National Australian HCV Point-of-Care Testing Program

NCT ID: NCT05042544

The National Australian HCV Point-of-Care Testing Program is a study aimed at improving the diagnosis and treatment of hepatitis C (HCV), a viral infection that can harm the liver. The researchers ...